WHO_RAISED_WHAT
roundscompaniessectorsmultiplesinvestorspeoplefundsgraphgossip
>/
browsesector narrativesindustriescountriesstagesstackmapAI supply chainstats
machinesapillms.txtchanges feed
aboutprovenanceobjectionschanges
CC-BY-4.0

companies / cisternabx-com

Cisterna Biologics

Stock summary

Generated 2026-11-09 UTC · publication cutoff 2026-11-09

Insufficient cited evidence for a two-sentence summary.

Business description
  • High quality mRNA for therapeutic application

    Evidence · 1 citation
    • Y Combinator · retrieved 2026-09-27

verified=2026-09-27   json

total_raisednullnull○
foundednull
hqSan Diego, CA, USA
industryunknown
stagenull

High quality mRNA for therapeutic application

acquisitions n=0

No cited completed company acquisition recorded.

traction n=0

Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.

No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.

valuations n=0

No cited valuation with an explicit basis is recorded.

revenue multiples n=0

Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.

No qualifying pair recorded.

rounds n=0

No funding round is documented for this company.

people n=1

personrolesrc
Hari BhaskaranfounderYC
Hari BhaskaranYC
founder

investors n=0

No investor is documented for this company.

provenance

factstatussrc
existencesourcedYC
descriptionsourcedYC
existenceYC
sourced
descriptionYC
sourced

change_history

datefactchangesrc
2026-09-27company_added: added, YC 2026-09-27company_addedaddedYC 2026-09-27
2026-09-27latest_round: Funding round, undisclosed → unknown, nulllatest_roundFunding round, undisclosed → unknownnull

Records begin 2026-09-24. all_changes